Back
ESC2025 Premium Access

Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis

Session: Novel pharmacological approaches in acute coronary syndromes
Topic: Pharmacotherapy
Speaker: Mr V. Oliveira (Goiania, BR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Vinicius Oliveira

Goiania (Brazil)
0 follower

5 more presentations in this session

Heart rate and cardiovascular outcomes with and without beta-blocker in post-mi patients: a pre-specified analysis of the ABYSS trial.

Speaker: Associate Professor M. Zeitouni (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)

Speaker: Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)

Access
Abstract
Slides
Like
Thumbnail

PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study

Speaker: Doctor J. Ren (Tianjin, CN)

Access
Abstract
Slides
Like
Thumbnail

Early PCSK9 inhibitor subscription during episode of acute myocardial infarction (EPISODE-AMI) study

Speaker: Professor C. Su (Taichung, TW)

Access
Abstract
Slides
Like
Thumbnail

Long-term outcomes of prasugrel-based de-escalation versus conventional therapy after PCI in ACS patients

Speaker: Mr J. Yun (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Novel pharmacological approaches in acute coronary syndromes

Speakers: Mr V. Oliveira, Associate Professor M. Zeitouni, Professor I. Spyridopoulos, Doctor J. Ren, Professor C. Su...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources